Detalhe da pesquisa
1.
Multivalent adaptor proteins specifically target NK cells carrying a universal chimeric antigen receptor to ErbB2 (HER2)-expressing cancers.
Cancer Immunol Immunother
; 72(9): 2905-2918, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36688995
2.
Genetically engineered CAR NK cells display selective cytotoxicity against FLT3-positive B-ALL and inhibit in vivo leukemia growth.
Int J Cancer
; 145(7): 1935-1945, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30860598
3.
Dual Targeting of Glioblastoma Cells with Bispecific Killer Cell Engagers Directed to EGFR and ErbB2 (HER2) Facilitates Effective Elimination by NKG2D-CAR-Engineered NK Cells.
Cells
; 13(3)2024 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38334638
4.
Surface charge-modification prevents sequestration and enhances tumor-cell specificity of a recombinant granzyme B-TGFα fusion protein.
Bioconjug Chem
; 23(8): 1567-76, 2012 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22759275
5.
Bispecific antibody-mediated redirection of NKG2D-CAR natural killer cells facilitates dual targeting and enhances antitumor activity.
J Immunother Cancer
; 9(10)2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34599028
6.
CD33 Delineates Two Functionally Distinct NK Cell Populations Divergent in Cytokine Production and Antibody-Mediated Cellular Cytotoxicity.
Front Immunol
; 12: 798087, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35058934
7.
Directed Differentiation of Mobilized Hematopoietic Stem and Progenitor Cells into Functional NK cells with Enhanced Antitumor Activity.
Cells
; 9(4)2020 03 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32230942
8.
"UniCAR"-modified off-the-shelf NK-92 cells for targeting of GD2-expressing tumour cells.
Sci Rep
; 10(1): 2141, 2020 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32034289
9.
Mutations associated with retinopathies alter mitogen-activated protein kinase-induced phosphorylation of neural retina leucine-zipper.
Mol Vis
; 13: 1114-20, 2007 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-17653056
10.
Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity.
Front Immunol
; 8: 533, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28572802
11.
Arming NK cells with enhanced antitumor activity: CARs and beyond.
Oncoimmunology
; 2(8): e25220, 2013 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24167761
12.
EGFR-targeted granzyme B expressed in NK cells enhances natural cytotoxicity and mediates specific killing of tumor cells.
PLoS One
; 8(4): e61267, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23573299
13.
Maltose-binding protein enhances secretion of recombinant human granzyme B accompanied by in vivo processing of a precursor MBP fusion protein.
PLoS One
; 5(12): e14404, 2010 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-21203542